FIELD: medicine. SUBSTANCE: method involves carrying out transcranial electric stimulation with 77 Hz current and curative dose of 2.6-2.8 mA. Then leukinferon is administered as turundas into the anterior nasal passage for 3-4 h during 6 days and phonophoresis with leukinferon ointment is applied to the ethmoidal labyrinth area during 4 days. EFFECT: enhanced effectiveness of treatment; reduced number of recurrence cases. 2 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR TREATING POLYPOID RHINOSINUSITIS | 1998 |
|
RU2138233C1 |
TREATMENT METHOD OF POLYPOUS RHINOSINUSITIS DURING POST-OPERATION PERIOD | 2007 |
|
RU2368404C2 |
METHOD OF TREATING POLYPOSIS RHINOSINUSITIS | 1998 |
|
RU2140215C1 |
METHOD FOR TREATING CHRONIC POLYPOUS RHINOSINUSITIS | 2000 |
|
RU2163097C1 |
PREDICTION METHOD OF POLYPOUS RHINOSINUSITIS RELAPSE RISK FOR PREVENTIVE THERAPY INDICATIONS | 2007 |
|
RU2338205C1 |
METHOD OF TREATING CHRONIC RECURRING INFLAMMATORY DISEASES OF NASAL CAVITY AND PARANASAL SINISES BY METHOD OF ENDONASAL AUTOLYMPHOCYTO THERAPY | 2009 |
|
RU2403071C1 |
METHOD FOR TREATING NASAL POLYPS | 2001 |
|
RU2190362C1 |
METHOD OF TREATING CHRONIC RHINOSINUSITIS | 2011 |
|
RU2469737C1 |
METHOD OF TREATMENT OF CHRONIC PHARYNGITIS ON BACKGROUND OF INTESTINE DYSBACTERIOSIS | 1999 |
|
RU2185841C2 |
METHOD OF TREATING PATIENTS WITH ALLERGIC RHINITIS WITH DISTURBED MICROBE LANDSCAPE OF NASAL MUCOSA | 2019 |
|
RU2711525C1 |
Authors
Dates
2000-10-10—Published
1998-11-16—Filed